Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Cu-Uvin

Showing results (101-110 of 134) with videos related to

Pageof 14
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|December 6, 2006
T-lymphocyte profile and total and virus-specific immunoglobulin concentrations in the cervix of HIV-1-infected womenAlison J Quayle, Athena P Kourtis, Susan Cu-Uvin, et al.
Plos One|July 9, 2010
Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodiesMimi Ghosh, John V Fahey, Zheng Shen, et al.
Journal of Lower Genital Tract Disease|November 19, 2015
An Insight Into Cervical Cancer Screening and Treatment Capacity in Sub Saharan AfricaJenell S Coleman, Michelle S Cespedes, Susan Cu-Uvin, et al.
AIDS (London, England)|September 10, 2003
Directly observed antiretroviral therapy to reduce genital tract and plasma HIV-1 RNA in women with poor adherenceJoseph I Harwell, Timothy P Flanigan, Jennifer A Mitty, et al.
Open Forum Infectious Diseases|January 12, 2023
Human Immunodeficiency Virus Type 1 RNA Genital Tract Shedding After Cryotherapy for Cervical Intraepithelial Neoplasia in Western KenyaElkanah Omenge Orang'o, Anne E Bocage, Tao D Liu, et al.
Obstetrics and Gynecology|May 27, 2010
High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral sheddingRegan N Theiler, Sherry L Farr, John M Karon, et al.
American Journal of Obstetrics and Gynecology|April 25, 2003
Substance use and psychotherapeutic medications: a likely contributor to menstrual disorders in women who are seropositive for human immunodeficiency virusSiobán D Harlow, Mardge Cohen, Suzanne E Ohmit, et al.
Journal of the International AIDS Society|June 27, 2024
Gestational weight gain and adverse birth outcomes in South African women with HIV on antiretroviral therapy and without HIV: a prospective cohort studyHlengiwe P Madlala, Landon Myer, Jennifer Jao, et al.
Frontiers in Cellular and Infection Microbiology|August 23, 2021
Protozoan-Viral-Bacterial Co-Infections Alter Galectin Levels and Associated Immunity Mediators in the Female Genital TractRaina N Fichorova, Allison K DeLong, Susan Cu-Uvin, et al.
Pediatrics|May 16, 2012
Infant outcomes after maternal antiretroviral exposure in resource-limited settingsKarin Nielsen-Saines, Lauren Komarow, Susan Cu-Uvin, et al.
Pageof 14

Showing results (101-110 of 134) with videos related to

Sort By:
Pageof 14
Journal of Acquired Immune Deficiency Syndromes (1999)|December 6, 2006
T-lymphocyte profile and total and virus-specific immunoglobulin concentrations in the cervix of HIV-1-infected womenAlison J Quayle, Athena P Kourtis, Susan Cu-Uvin, et al.
Plos One|July 9, 2010
Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodiesMimi Ghosh, John V Fahey, Zheng Shen, et al.
Journal of Lower Genital Tract Disease|November 19, 2015
An Insight Into Cervical Cancer Screening and Treatment Capacity in Sub Saharan AfricaJenell S Coleman, Michelle S Cespedes, Susan Cu-Uvin, et al.
AIDS (London, England)|September 10, 2003
Directly observed antiretroviral therapy to reduce genital tract and plasma HIV-1 RNA in women with poor adherenceJoseph I Harwell, Timothy P Flanigan, Jennifer A Mitty, et al.
Open Forum Infectious Diseases|January 12, 2023
Human Immunodeficiency Virus Type 1 RNA Genital Tract Shedding After Cryotherapy for Cervical Intraepithelial Neoplasia in Western KenyaElkanah Omenge Orang'o, Anne E Bocage, Tao D Liu, et al.
Obstetrics and Gynecology|May 27, 2010
High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral sheddingRegan N Theiler, Sherry L Farr, John M Karon, et al.
American Journal of Obstetrics and Gynecology|April 25, 2003
Substance use and psychotherapeutic medications: a likely contributor to menstrual disorders in women who are seropositive for human immunodeficiency virusSiobán D Harlow, Mardge Cohen, Suzanne E Ohmit, et al.
Journal of the International AIDS Society|June 27, 2024
Gestational weight gain and adverse birth outcomes in South African women with HIV on antiretroviral therapy and without HIV: a prospective cohort studyHlengiwe P Madlala, Landon Myer, Jennifer Jao, et al.
Frontiers in Cellular and Infection Microbiology|August 23, 2021
Protozoan-Viral-Bacterial Co-Infections Alter Galectin Levels and Associated Immunity Mediators in the Female Genital TractRaina N Fichorova, Allison K DeLong, Susan Cu-Uvin, et al.
Pediatrics|May 16, 2012
Infant outcomes after maternal antiretroviral exposure in resource-limited settingsKarin Nielsen-Saines, Lauren Komarow, Susan Cu-Uvin, et al.
Pageof 14